Zydus Gets USFDA Approval for Methenamine Hippurate Tablets USP, 1g
Ahmedabad, India, 12 March, 2025 Zydus Lifesciences Limited (including its subsidiaries/ affiliates, hereafter referred to as “Zydus”) has received final approval from the United States Food and Drug Administration (USFDA) to manufacture Methenamine Hippurate Tablets […]
